Robert Eugene Kennedy

This profile gathers the share dealings of Robert Eugene Kennedy in SELLAS Life Sciences Group, Inc. In total, 3 filings cover trades dated 13 April 2011.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 22 April 2011: a share grant, in SELLAS Life Sciences Group, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 9 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.